Evidence map›Paper›PMID 38995531›Full record

ArticleCell biochemistry and biophysics2024

Blockade of PD-1 and TIM-3 Ameliorates CD8

Ting Jin, Fei Gao, Li Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ting JinDepartment of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Fei GaoDepartment of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Li WangDepartment of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China. wlmarx96@163.com.

Funding

2022 Hubei Provincial Natural Science Foundation Youth Project 2022CFB797China Primary Health Care Foundation cphcf-2023-101
6 · The paper itself

Abstract

The immune system plays a pivotal role in controlling chronic myeloid leukemia (CML). CD8

Indexed as

CD8-Positive T-LymphocytesDisease Models, AnimalHepatitis A Virus Cellular Receptor 2Leukemia, Myelogenous, Chronic, BCR-ABL PositiveProgrammed Cell Death 1 ReceptorT-Cell ExhaustionAnimalsCytokinesMiceMice, Inbred C57BLCytokinesHavcr2 protein, mouseHepatitis A Virus Cellular Receptor 2Pdcd1 protein, mouseProgrammed Cell Death 1 Receptorchronic myeloid leukemiaPD-1T cell exhaustionTIM-3

Identifiers

PMID38995531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.